Correspondence 0001062993-25-004733 from Medicus Pharma Ltd. (MDCX)

Medicus Pharma Ltd.
Date: March 6, 2025 · CIK: 0001997296 · Accession: 0001062993-25-004733

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 024-12573

Date

March 6, 2025

Author

By: /s/ Raza Bokhari

Form

CORRESP

Company

Medicus Pharma Ltd.

Letter

VIA EDGAR Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Alan Campbell Re: Medicus Pharma Ltd. Offering Statement on Form 1-A Originally Filed February 14, 2025 CIK: CIK0001997296

Dear Ladies and Gentlemen:

We hereby request that the qualification date of the Offering Statement on Form 1-A, File No. 024-12573, as amended (the "Offering Statement"), relating to the offering of up to 2,222,222 units, each consisting of one common share, no par value, and one warrant to purchase one common share, of Medicus Pharma Ltd. (the "Company") be accelerated to March 6, 2025 at 5:00 PM ET or as soon thereafter as may be practicable.

Please contact Christopher J. Cummings of Paul, Weiss, Rifkind, Wharton & Garrison LLP, special counsel to the Company, at (212) 373-3434, as soon as the Offering Statement has been qualified, or if you have any other questions or concerns regarding this matter.

*****

Very truly yours,
By: /s/ Raza Bokhari

Show Raw Text

CORRESP
1
filename1.htm

    Medicus Pharma Ltd.: CORRESP - Filed by newsfilecorp.com

    Medicus Pharma Ltd.

    300 Conshohocken State Rd. Suite 200
W. Conshohocken, PA 19428

    March 6, 2025

    VIA EDGAR

Division of Corporation Finance

    Office of Life Sciences

    Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

    Attention: Alan Campbell

    Re:  Medicus Pharma Ltd.
Offering Statement on Form 1-A
Originally Filed February 14, 2025
CIK: CIK0001997296

    Dear Ladies and Gentlemen:

    We hereby request that the qualification date of the Offering Statement on Form 1-A, File No. 024-12573, as amended (the "Offering Statement"), relating to the offering of up to 2,222,222 units, each consisting of one common share, no par value, and one warrant to purchase one common share, of Medicus Pharma Ltd. (the "Company") be accelerated to March 6, 2025 at 5:00 PM ET or as soon thereafter as may be practicable.

    Please contact Christopher J. Cummings of Paul, Weiss, Rifkind, Wharton & Garrison LLP, special counsel to the Company, at (212) 373-3434, as soon as the Offering Statement has been qualified, or if you have any other questions or concerns regarding this matter.

    *****

    Very truly yours,

    By:  /s/ Raza Bokhari

    Name: Dr. Raza Bokhari

    Title:  Executive Chairman and Chief Executive Officer

SecProbe.io